The Offices of United States Senator Richard Burr and United States Senator Thom Tillis, the North Carolina Military Business Center, the North Carolina Biotechnology Center and the University of North Carolina are pleased to host the Medical, Biomedical & Biodefense: Support to the Warfighter Symposium.
Medical Support to the Warfighter, will connect businesses in North Carolina with military and other federal agencies that require or purchase medical supplies, equipment, devices, pharmaceuticals, medical information technology and medical services. Representatives from the Departments of Defense, Veterans Affairs and Health and Human Services, their prime vendors and major contractors – from national commands and from bases, commands and facilities in North Carolina – will highlight current technology or resource gaps and needs, future requirements and procurement processes to supply military and federal medical facilities and agencies. All medical-related businesses in North Carolina – large or small, prime contractors, subcontractors, suppliers, manufacturers and service providers – will benefit from briefings on military requirements, procurement processes and supplier qualifications, from informal networking with buyers and users, and from exhibiting or viewing demonstrations of the latest medical technologies designed to support America’s warfighters.
The Biomedical and Biodefense Support to the Warfighter portion of this conference will be split with a focus on traditional biodefense R&D topics in our morning breakout and a focus on military medical R&D topics in our afternoon session. Each session will include a federal representative from these topical areas who will highlight the government’s challenges, needs and priority areas of interest. Each panel will also include a researcher and/or industry partner that are developing technology solutions that address some of the problem areas. Each session will conclude with a panel discussion regarding challenges and opportunities for funding and collaboration. Both of these sessions aim to establish a dialogue between industry, academia and government to form partnerships to address the future biomedical and biodefense technology needs of the military and our nation.